Aegerion appoints Paul Merrigan marketing VP
This article was originally published in Scrip
Executive Summary
Aegerion Pharmaceuticals, a biopharmaceutical company developing novel therapeutics to treat severe lipid disorders, has appointed Paul Merrigan vice-president of global marketing. Mr Merrigan most recently served as vice-president and general manager of neuromuscular diseases at Genzyme, where he had previously held many other positions.